New markers in Parkinson's disease

被引：22

作者：

Bougea, Anastasia ^{[1
,2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol & Movement Disorders 1, Neurochem Lab,Med Sch, Athens, Greece

[2] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Neurosci Lab, Athens, Greece

来源：

ADVANCES IN CLINICAL CHEMISTRY, VOL 96 | 2020年 / 96卷

关键词：

FLUID ALPHA-SYNUCLEIN; MILD COGNITIVE IMPAIRMENT; SERUM URIC-ACID; CEREBROSPINAL-FLUID; MOTOR PROGRESSION; DIFFERENTIAL-DIAGNOSIS; CLINICAL-DIAGNOSIS; NATURAL-HISTORY; CSF BIOMARKERS; DECLINE;

D O I：

10.1016/bs.acc.2019.12.001

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Parkinson's disease (PD) is a chronic, debilitating neurodegenerative disorder characterized clinically by a variety of progressive motor and nonmotor symptoms. Currently, there is a dearth of diagnostic tools available to predict, diagnose or mitigate disease risk or progression, leading to a challenging dilemma within the healthcare management system. The search for a reliable biomarker for PD that reflects underlying pathology is a high priority in PD research. Currently, there is no reliable single biomarker predictive of risk for motor and cognitive decline, and there have been few longitudinal studies of temporal progression. A combination of multiple biomarkers might facilitate earlier diagnosis and more accurate prognosis in PD. In this review, we focus on the recent developments of serial biomarkers for PD from a variety of clinical, biochemical, genetic and neuroimaging perspectives.

引用

页码：137 / 178

页数：42

共 143 条

[101] Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease [J].

Parnetti, Lucilla ;

Chiasserini, Davide ;

Persichetti, Emanuele ;

Eusebi, Paolo ;

Varghese, Shiji ;

Qureshi, Mohammad M. ;

Dardis, Andrea ;

Deganuto, Marta ;

De Carlo, Claudia ;

Castrioto, Anna ;

Balducci, Chiara ;

Paciotti, Silvia ;

Tambasco, Nicola ;

Bembi, Bruno ;

Bonanni, Laura ;

Onofrj, Marco ;

Rossi, Aroldo ;

Beccari, Tommaso ;

El-Agnaf, Omar ;

Calabresi, Paolo .

MOVEMENT DISORDERS, 2014, 29 (08) :1019-1027

[102] Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease [J].

Parnetti, Lucilla ;

Farotti, Lucia ;

Eusebi, Paolo ;

Chiasserini, Davide ;

De Carlo, Claudia ;

Giannandrea, David ;

Salvadori, Nicola ;

Lisetti, Viviana ;

Tambasco, Nicola ;

Rossi, Aroldo ;

Majbour, Nour K. ;

El-Agnaf, Omar ;

Calabresi, Paolo .

FRONTIERS IN AGING NEUROSCIENCE, 2014, 6

[103] Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug- na_iveParkinson's disease [J].

Pellecchia, M. T. ;

Santangelo, G. ;

Picillo, M. ;

Pivonello, R. ;

Longo, K. ;

Pivonello, C. ;

Vitale, C. ;

Amboni, M. ;

De Rosa, A. ;

Moccia, M. ;

Erro, R. ;

De Michele, G. ;

Santoro, L. ;

Colao, A. ;

Barone, P. .

EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (05) :802-807

[104] Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study [J].

Pellecchia, Maria Teresa ;

Savastano, Riccardo ;

Moccia, Marcello ;

Picillo, Marina ;

Siano, Pietro ;

Erro, Roberto ;

Vallelunga, Annamaria ;

Amboni, Marianna ;

Vitale, Carmine ;

Santangelo, Gabriella ;

Barone, Paolo .

JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (12) :1399-1402

[105] Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naive Parkinson's disease [J].

Picillo, Marina ;

Erro, Roberto ;

Santangelo, Gabriella ;

Pivonello, Rosario ;

Longo, Katia ;

Pivonello, Claudia ;

Vitale, Carmine ;

Amboni, Marianna ;

Moccia, Marcello ;

Colao, Annamaria ;

Barone, Paolo ;

Pellecchia, Maria Teresa .

JOURNAL OF NEUROLOGY, 2013, 260 (07) :1724-1730

[106] Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [J].

Polymeropoulos, MH ;

Lavedan, C ;

Leroy, E ;

Ide, SE ;

Dehejia, A ;

Dutra, A ;

Pike, B ;

Root, H ;

Rubenstein, J ;

Boyer, R ;

Stenroos, ES ;

Chandrasekharappa, S ;

Athanassiadou, A ;

Papapetropoulos, T ;

Johnson, WG ;

Lazzarini, AM ;

Duvoisin, RC ;

DiIorio, G ;

Golbe, LI ;

Nussbaum, RL .

SCIENCE, 1997, 276 (5321) :2045-2047

[107] MDS clinical diagnostic criteria for Parkinson's disease [J].

Postuma, Ronald B. ;

Berg, Daniela ;

Stern, Matthew ;

Poewe, Werner ;

Olanow, C. Warren ;

Oertel, Wolfgang ;

Obeso, Jose ;

Marek, Kenneth ;

Litvan, Irene ;

Lang, Anthony E. ;

Halliday, Glenda ;

Goetz, Christopher G. ;

Gasser, Thomas ;

Dubois, Bruno ;

Chan, Piu ;

Bloem, Bastiaan R. ;

Adler, Charles H. ;

Deuschl, Guenther .

MOVEMENT DISORDERS, 2015, 30 (12) :1591-1599

[108] Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro [J].

Qureshi, Hamid Y. ;

Paudel, Hemant K. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (07) :5055-5068

[109] Parkinson's progression prediction using machine learning and serum cytokines [J].

Rastegar, Diba Ahmadi ;

Ho, Nicholas ;

Halliday, Glenda M. ;

Dzamko, Nicolas .

NPJ PARKINSONS DISEASE, 2019, 5 (1)

[110] Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study [J].

Reinoso, G. ;

Allen, J. C., Jr. ;

Au, W. -L. ;

Seah, S. -H. ;

Tay, K. -Y. ;

Tan, L. C. S. .

EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (03) :457-463

← 6 7 8 9 10 11 12 13 14 15 →